Q4 2022 Holdings
Filed 2023-02-13 | 23 holdings | $375.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prometheus Biosciences Inc | COM | 74349U108 | $101.6M | 923,800 | 27.1% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $61.3M | 3,169,892 | 16.3% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $47.6M | 5,492,893 | 12.7% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $41.2M | 2,800,126 | 11.0% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $35.0M | 3,317,544 | 9.3% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $14.3M | 3,473,366 | 3.8% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $14.2M | 2,829,712 | 3.8% |
| Kezar Life Sciences Inc | COM | 49372L100 | $13.3M | 1,889,451 | 3.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $10.3M | 215,059 | 2.8% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $6.0M | 1,055,882 | 1.6% |
| Rallybio Corp | COM | 75120L100 | $4.8M | 726,109 | 1.3% |
| Ikena Oncology Inc | COM | 45175G108 | $4.4M | 1,637,372 | 1.2% |
| Precision Biosciences Inc | COM | 74019P108 | $4.2M | 3,549,820 | 1.1% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $3.1M | 333,252 | 0.8% |
| Orchard Therapeutics PLC | SPON ADS | 68570P101 | $3.0M | 7,987,396 | 0.8% |
| Inozyme Pharma Inc | COM | 45790W108 | $2.3M | 2,204,876 | 0.6% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $2.3M | 4,814,419 | 0.6% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.0M | 2,384,402 | 0.5% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $1.8M | 333,945 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.6M | 864,822 | 0.4% |
| Oncorus Inc | COM | 68236R103 | $599.7K | 2,367,436 | 0.2% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $431.3K | 25,000 | 0.1% |
| Pliant Therapeutics Inc(PLRX)Call | COM | 729139105 | $29.3K | 30,000 | 0.0% |